ABOS - Acumen Pharmaceuticals Inc. (ABOS) Q4 2023 Earnings Call Transcript
2024-03-26 10:45:17 ET
Acumen Pharmaceuticals, Inc. (ABOS)
Q4 2023 Earnings Conference Call
March 26, 2024 08:00 A.M. ET
Company Participants
Alex Braun - Head, IR
Daniel O'Connell - CEO
Eric Siemers - Chief Medical Officer
Matthew Zuga - CFO & Chief Business Officer
Jim Doherty - President and Chief Development Officer
Conference Call Participants
Neena Bitritto-Garg - Deutsche Bank
Unidentified Analyst - BTIG
Unidentified Analyst - Stifel, Nicolaus & Company
Unidentified Analyst - UBS
Unidentified Analyst - Bank of America
Ananda Ghosh - H.C. Wainwright
Presentation
Operator
Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would like now to turn the conference over to Alex Braun, Head of Investor Relations. Please go ahead.
Alex Braun
Thanks Michelle. Good morning, and welcome to the Acumen conference call to discuss our business update and financial results for the year ended December 31, 2023. With me today are Dan O'Connell, our Chief Executive Officer; Dr. Jim Doherty, our President and Chief Development Officer; Dr. Eric Siemers, our Chief Medical Officer; and Matt Zuga, our Chief Financial Officer and Chief Business Officer....
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript